OBJECTIVE: We aimed to identify novel, functional, replicable and genome-wide significant risk regions specific for alcohol dependence using genome-wide association studies (GWASs). METHODS: A discovery sample (1409 European-American cases with alcohol dependence and 1518 European-American controls) and a replication sample (6438 European-Australian family subjects with 1645 alcohol dependent probands) underwent association analysis. Nineteen other cohorts with 11 different neuropsychiatric disorders served as contrast groups. Additional eight samples underwent expression quantitative locus (eQTL) analysis. RESULTS: A genome-wide significant risk gene region (NKAIN1-SERINC2) was identified in a meta-analysis of the discovery and replication samples. This region was enriched with 74 risk SNPs (unimputed); half of them had significant cis-acting regulatory effects. The distributions of -log(p) values for the SNP-disease associations or SNP-expression associations in this region were consistent throughout eight independent samples. Furthermore, imputing across the NKAIN1-SERINC2 region, we found that among all 795 SNPs in the discovery sample, 471 SNPs were nominally associated with alcohol dependence (1.7×10(-7)≤p≤0.047); 53 survived region- and cohort-wide correction for multiple testing; 92 SNPs were replicated in the replication sample (0.002≤p≤0.050). This region was neither significantly associated with alcohol dependence in African-Americans, nor with other non-alcoholism diseases. Finally, transcript expression of genes in NKAIN1-SERINC2 was significantly (p<3.4×10(-7)) associated with expression of numerous genes in the neurotransmitter systems or metabolic pathways previously associated with alcohol dependence. CONCLUSION: NKAIN1-SERINC2 may harbor a causal variant(s) for alcohol dependence. It may contribute to the disease risk by way of neurotransmitter systems or metabolic pathways.
OBJECTIVE: We aimed to identify novel, functional, replicable and genome-wide significant risk regions specific for alcohol dependence using genome-wide association studies (GWASs). METHODS: A discovery sample (1409 European-American cases with alcohol dependence and 1518 European-American controls) and a replication sample (6438 European-Australian family subjects with 1645 alcohol dependent probands) underwent association analysis. Nineteen other cohorts with 11 different neuropsychiatric disorders served as contrast groups. Additional eight samples underwent expression quantitative locus (eQTL) analysis. RESULTS: A genome-wide significant risk gene region (NKAIN1-SERINC2) was identified in a meta-analysis of the discovery and replication samples. This region was enriched with 74 risk SNPs (unimputed); half of them had significant cis-acting regulatory effects. The distributions of -log(p) values for the SNP-disease associations or SNP-expression associations in this region were consistent throughout eight independent samples. Furthermore, imputing across the NKAIN1-SERINC2 region, we found that among all 795 SNPs in the discovery sample, 471 SNPs were nominally associated with alcohol dependence (1.7×10(-7)≤p≤0.047); 53 survived region- and cohort-wide correction for multiple testing; 92 SNPs were replicated in the replication sample (0.002≤p≤0.050). This region was neither significantly associated with alcohol dependence in African-Americans, nor with other non-alcoholism diseases. Finally, transcript expression of genes in NKAIN1-SERINC2 was significantly (p<3.4×10(-7)) associated with expression of numerous genes in the neurotransmitter systems or metabolic pathways previously associated with alcohol dependence. CONCLUSION:NKAIN1-SERINC2 may harbor a causal variant(s) for alcohol dependence. It may contribute to the disease risk by way of neurotransmitter systems or metabolic pathways.
Authors: C H Bau; S Almeida; F T Costa; C E Garcia; E P Elias; A C Ponso; A Spode; M H Hutz Journal: Mol Psychiatry Date: 2001-01 Impact factor: 15.992
Authors: Lingjun Zuo; Joel Gelernter; Clarence K Zhang; Hongyu Zhao; Lingeng Lu; Henry R Kranzler; Robert T Malison; Chiang-Shan R Li; Fei Wang; Xiang-Yang Zhang; Hong-Wen Deng; John H Krystal; Fengyu Zhang; Xingguang Luo Journal: Neuropsychopharmacology Date: 2011-09-28 Impact factor: 7.853
Authors: Howard J Edenberg; Daniel L Koller; Xiaoling Xuei; Leah Wetherill; Jeanette N McClintick; Laura Almasy; Laura J Bierut; Kathleen K Bucholz; Alison Goate; Fazil Aliev; Danielle Dick; Victor Hesselbrock; Anthony Hinrichs; John Kramer; Sam Kuperman; John I Nurnberger; John P Rice; Marc A Schuckit; Robert Taylor; B Todd Webb; Jay A Tischfield; Bernice Porjesz; Tatiana Foroud Journal: Alcohol Clin Exp Res Date: 2010-03-01 Impact factor: 3.455
Authors: Martin Reichel; Johannes Beck; Christiane Mühle; Andrea Rotter; Stefan Bleich; Erich Gulbins; Johannes Kornhuber Journal: Alcohol Clin Exp Res Date: 2011-05-19 Impact factor: 3.455
Authors: Shaunna L Clark; Joseph L McClay; Daniel E Adkins; Gaurav Kumar; Karolina A Aberg; Srilaxmi Nerella; Linying Xie; Ann L Collins; James J Crowley; Corey R Quackenbush; Christopher E Hilliard; Andrey A Shabalin; Scott I Vrieze; Roseann E Peterson; William E Copeland; Judy L Silberg; Matt McGue; Hermine Maes; William G Iacono; Patrick F Sullivan; Elizabeth J Costello; Edwin J van den Oord Journal: Alcohol Clin Exp Res Date: 2017-03-24 Impact factor: 3.455
Authors: Leslie A Brick; Matthew C Keller; Valerie S Knopik; John E McGeary; Rohan H C Palmer Journal: Addict Biol Date: 2017-11-27 Impact factor: 4.280
Authors: Dilafruz Juraeva; Jens Treutlein; Henrike Scholz; Josef Frank; Franziska Degenhardt; Sven Cichon; Monika Ridinger; Manuel Mattheisen; Stephanie H Witt; Maren Lang; Wolfgang H Sommer; Per Hoffmann; Stefan Herms; Norbert Wodarz; Michael Soyka; Peter Zill; Wolfgang Maier; Elisabeth Jünger; Wolfgang Gaebel; Norbert Dahmen; Norbert Scherbaum; Christine Schmäl; Michael Steffens; Susanne Lucae; Marcus Ising; Michael N Smolka; Ulrich S Zimmermann; Bertram Müller-Myhsok; Markus M Nöthen; Karl Mann; Falk Kiefer; Rainer Spanagel; Benedikt Brors; Marcella Rietschel Journal: Neuropsychopharmacology Date: 2014-07-18 Impact factor: 7.853
Authors: J Gelernter; H R Kranzler; R Sherva; L Almasy; R Koesterer; A H Smith; R Anton; U W Preuss; M Ridinger; D Rujescu; N Wodarz; P Zill; H Zhao; L A Farrer Journal: Mol Psychiatry Date: 2013-10-29 Impact factor: 15.992